skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.10e (Release date: 2017-10-30)
SearchBox Top
SearchBox Bottom
Bevacizumab-IRDye 800CW (Code C101261)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Bevacizumab-IRDye 800CW

Definition: An immunoconjugate and a fluorescent tracer consisting of the recombinant humanized anti-vascular endothelial growth factor (VEGF) monoclonal antibody bevacizumab conjugated to the N-hydroxysuccinamide (NHS) ester form of the near-infrared (NIR) fluorescent dye IRDye 800CW, that may be used for VEGF-specific tumor imaging. Upon administration, the bevacizumab moiety of bevacizumab-IRDye 800CW binds to VEGF and the fluorescent signal can be visualized using NIR fluorescence imaging (700-1,000 nm).

Label: Bevacizumab-IRDye 800CW

NCI Thesaurus Code: C101261 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL435509  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Bevacizumab-IRDye 800CW

External Source Codes: 
PDQ Closed Trial Search ID 729590
PDQ Open Trial Search ID 729590 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C101261
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom